Under insulin resistance/hyperinsulinemia, ET-1 can suppress insulin-induced Akt activation in VSMCs to exacerbate the development of hypertension and atherosclerosis (Lin et al., 2015). The gene discussed is INS; the disease is hyperinsulinism.